在区域抗生素管理协作中进行的万科米辛AUC剂量计划
Peter Pasek1, Joseph Hong1, Joe Pardo2
1Bay Pines Veterans Affairs Healthcare System, Florida.
概括
退伍军人事务网络中的抗生素管理计划 (ASP) 改善了抗菌素的使用. 在VISN 8中的一个协作模型成功地通过实施AUC引导的万科米辛剂量来减少急性损伤.
科学领域:
- 医疗保健服务研究 医疗服务研究
- 传染性疾病 传染性疾病
- 药理学 药理学是指药理学的学科.
背景情况:
- 抗生素管理计划 (ASP) 是退伍军人卫生管理局 (VHA) 在所有设施中授权的.
- 需要区域退伍军人综合服务网络 (VISNs) 来开发ASP协作.
- 2015年,VISN 8为超过150万退伍军人提供服务,并建立了一个模范的ASP工作组.
研究的目的:
- 评估区域ASP协作模式的有效性.
- 评估VHA内部多站点质量倡议的影响.
- 为了证明VHA在抗菌药物管理方面的领导地位.
主要方法:
- 每个医疗中心的ASP冠军组成的VISN 8 ASP工作组每月举行一次会议.
- 这项合作促进了多站点质量倡议的实施区域,在曲线 (AUC) 导向的米素剂量下.
- 进行质量保证评估以确定最佳实践.
主要成果:
- 在VISN 8内的4个医疗保健系统中实施了以AUC为指导的万科米辛剂量.
- 这种方法导致急性损伤率显著降低 (2.4%),而低谷基剂量 (10.4%).
- 质量保证评估确定了在VISN中传播的最佳实践.
结论:
- VISN 8 ASP工作组展示了有效的协作,以优化抗菌剂的使用和影响大型退伍军人群体.
- ASP协作利用集体规模进行强大的多站点质量保证评估.
- 这个模型的扩展凸显了VHA作为国家ASP最佳实践的领导者.
相关概念视频
01:27Combined Effects of Drugs: Synergism
3.7K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
3.7K
01:15Drug Dosage Regimen: Overview
3.4K
A drug dosage regimen describes the specific instructions and schedule for administering a drug to a patient. It considers factors such as drug dosage, frequency, route of administration, and duration of treatment. Designing an appropriate dosage regimen for a patient aims to achieve a target drug concentration at the site of action.
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...
3.4K
00:57Antibiotic Selection
52.2K
Overview
52.2K
01:24Rational Dosage Regimen: Maintenance Dose and Loading Dose
3.8K
A rational dosage regimen considers a drug's pharmacokinetics, including its absorption, distribution, metabolism, and elimination from the body. By understanding these factors, the appropriate dosage can be determined, and the dosing schedule can be designed to achieve and maintain the desired therapeutic effect while minimizing adverse effects.
In most cases, drugs are administered repetitively or infused continuously to maintain a steady-state concentration in the body. At a steady...
In most cases, drugs are administered repetitively or infused continuously to maintain a steady-state concentration in the body. At a steady...
3.8K
01:25Clearance Models: Compartment Models
47
Clearance measures drug elimination from the central compartment, including plasma and highly perfused organs like kidneys and liver. Its calculation varies depending on pharmacokinetic models and administration routes. The one-compartment model, for instance, portrays the pharmacokinetics of polar drugs such as aminoglycoside antibiotics administered intravenously and readily excreted in urine. In this case, clearance is influenced by the terminal rate constant (λz) and the total volume...
47
01:01Dosage Regimen: Fixed Dose
1.8K
Fixed-dose regimens are a common approach to administer drugs to achieve and maintain desired levels of the drug in the body. In this dosing strategy, a specific amount of medication is given at regular intervals, often multiple times a day, to ensure a consistent drug concentration in the bloodstream.
Fixed-dose regimens can be used for various routes of administration, including intravenous (IV) injections and oral medications. For IV administration, a predetermined amount of the drug is...
Fixed-dose regimens can be used for various routes of administration, including intravenous (IV) injections and oral medications. For IV administration, a predetermined amount of the drug is...
1.8K